Effects Of Dry Needling On Mobility Among Children With Cerebral Palsy

Last updated: January 10, 2025
Sponsor: Riphah International University
Overall Status: Completed

Phase

N/A

Condition

Cataplexy

Limb Spasticity

Dystonia

Treatment

Dry Needling

Cerebral Palsy conventional Treatment

Clinical Study ID

NCT06661421
REC/RCR&AHS/24/0701
  • Ages 6-12
  • All Genders

Study Summary

This study explores the potential of dry needling as a treatment for spasticity in the foot among children with cerebral palsy (CP). Dry needling involves inserting fine needles into specific trigger points or tight muscles without injecting any substances, aiming to relieve pain, improve muscle function, and promote tissue healing. In CP-related foot spasticity, dry needling may target hypertonic muscles, inducing a local twitch response that helps release muscle tension, reduce spasticity, and enhance overall muscle function. The technique may also stimulate sensory nerves and trigger the release of endorphins, contributing to pain relief and muscle relaxation.

While dry needling has shown effectiveness in reducing spasticity and improving muscle function in adults with conditions such as post-stroke, there is limited research on its benefits for children with CP. This randomized controlled trial aims to address this gap by evaluating the impact of dry needling on spasticity, range of motion, and functional mobility in children with CP.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age: 6 to 12 years old

  • Walking ability at Gross Motor Function Classification System levels I to II

  • Modified Modified Ashworth Scale (MAS) score higher than equal to 1 (score up to 2)

  • Ability to understand and execute orders

  • No ongoing rehabilitation intervention

Exclusion

Exclusion Criteria:

  • Recent introduction of a new intervention in addition to previous treatments

  • Presence of bleeding disorders or skin conditions

  • Skin sensitivity issues

  • History of seizures within the past six months

  • Previous administration of BTX-A injection within the last 6 months

  • Presence of

  • contraindications to dry needling

  • Lack of consent to participate in the study

Study Design

Total Participants: 38
Treatment Group(s): 2
Primary Treatment: Dry Needling
Phase:
Study Start date:
September 24, 2024
Estimated Completion Date:
January 01, 2025

Study Description

The study will be conducted at Bliss Center of Care and Therapy in Faisalabad, involving 38 participants aged 6 to 12 years, all diagnosed with spastic cerebral palsy and classified under the Gross Motor Function Classification System (GMFCS) levels I-II. Participants will be divided into two groups: an experimental group receiving dry needling therapy (DNT) and routine physical therapy (RPT) and a control group receiving RPT only. Critical exclusion criteria include recent interventions, bleeding disorders, fixed joint deformities, recent seizures, Botulinum Toxin injections, or contraindications to dry needling.

Outcomes will be measured using the Wartenberg Pendulum Test, Active and Passive Ankle Dorsiflexion Range of Motion, and the Timed Up and Go Test, which will be assessed before and after a 10-week intervention. Data will be analyzed using SPSS version 23.0 to determine the efficacy of dry needling in managing spasticity in children with CP.

Connect with a study center

  • Riphah International University

    Lahore, Punjab 54700
    Pakistan

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.